Yayın: Pyrazolyl‐Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer
| dc.contributor.author | Kani, İbrahim | |
| dc.contributor.author | Volkan Kamaci | |
| dc.contributor.author | Ceylan Özsoy | |
| dc.contributor.author | Yusuf Sert | |
| dc.contributor.author | İbrahim Kani | |
| dc.contributor.author | Lütfi Tutar | |
| dc.contributor.author | Yusuf Tutar | |
| dc.contributor.orcid | 0000-0001-7873-159X | |
| dc.contributor.orcid | 0000-0001-8836-8667 | |
| dc.contributor.orcid | 0000-0002-7654-6013 | |
| dc.contributor.orcid | 0000-0003-2613-9644 | |
| dc.date.accessioned | 2025-11-13T10:57:41Z | |
| dc.date.issued | 2022-05-17 | |
| dc.identifier.doi | https://doi.org/10.1002/slct.202200359 | |
| dc.identifier.issn | 2365-6549 | |
| dc.identifier.issue | 19 | |
| dc.identifier.openalex | W4280609947 | |
| dc.identifier.uri | https://hdl.handle.net/11421/5789 | |
| dc.identifier.uri | https://doi.org/10.1002/slct.202200359 | |
| dc.identifier.volume | 7 | |
| dc.language.iso | en | |
| dc.relation.ispartof | ChemistrySelect | |
| dc.rights | restrictedAccess | |
| dc.subject | Heat shock protein | |
| dc.subject | Hsp90 | |
| dc.subject | Apoptosis | |
| dc.subject | Cancer cell | |
| dc.subject | Chemistry | |
| dc.subject | Cytotoxic T cell | |
| dc.subject | Cell | |
| dc.subject | Chaperone (clinical) | |
| dc.subject | Protein folding | |
| dc.subject | Biochemistry | |
| dc.subject | Cancer research | |
| dc.subject | Cell biology | |
| dc.subject | Biology | |
| dc.subject | Cancer | |
| dc.subject | Medicine | |
| dc.subject | In vitro | |
| dc.subject.sdg | 3 | |
| dc.title | Pyrazolyl‐Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5021104813 |
